Cathespin cysteine protease inhibitors
    22.
    发明授权
    Cathespin cysteine protease inhibitors 有权
    夹心半胱氨酸蛋白酶抑制剂

    公开(公告)号:US07312353B2

    公开(公告)日:2007-12-25

    申请号:US10568495

    申请日:2004-08-19

    IPC分类号: C07C255/22 C07C229/24

    摘要: This invention relates to a novel class of compounds, represented by the formula below, wherein the meanings of G, E, E, n, R1, R2, R3 et R4 are indicated therein, which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsins K, L, S and B. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.

    摘要翻译: 本发明涉及由下式表示的新一类化合物,其中G,E,E,n,R 1,R 2,R 2, 其中指出其中的半胱氨酸蛋白酶抑制剂,包括但不限于组织蛋白酶K,L,S和B的抑制剂。这些化合物可用于治疗 指出了骨吸收抑制的疾病,例如骨质疏松症。

    Fluoroalkylamine Derivatives as Cathepsin Inhibtors
    28.
    发明申请
    Fluoroalkylamine Derivatives as Cathepsin Inhibtors 审中-公开
    氟烷基胺衍生物作为组织蛋白酶抑制剂

    公开(公告)号:US20090099264A1

    公开(公告)日:2009-04-16

    申请号:US11920338

    申请日:2006-05-30

    CPC分类号: C07C317/48 C07C2601/02

    摘要: The present invention provides compounds of formula I which are inhibitors of cathepsin S and as such are useful in the prevention and treatment of cathepsin S dependent diseases and conditions including, but not limited to, chronic obstructive pulmonary disease (COPD) and pain.

    摘要翻译: 本发明提供了作为组织蛋白酶S的抑制剂的式I化合物,因此可用于预防和治疗组织蛋白酶S依赖性疾病和病症,包括但不限于慢性阻塞性肺病(COPD)和疼痛。